+34 620 10 75 37info@nanbiosis.com
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) & Jesus Usón Minimally Invasive Surgery Center (JUMISC) 29 Jan Fabry disease therapy nanoGLA, developed by NANBIOSIS and our partners, shows superior efficacy in preclinical trials, targeting systemic and brain symptoms. Barcelona, january 2025. An international research team led by the Institute of Materials Science of Barcelona (ICMAB-CSIC) and CIBER-BBN,[...] 26 Dec NANBIOSIS Unit 9 advances glioblastoma treatment with tailored copper nanoparticles, reducing tumor invasiveness and opening new therapeutic pathways. Zaragoza, December 2024. Our Unit 9, specialized in nanoparticle synthesis, has achieved a breakthrough in the fight against glioblastoma, one of t[...] 29 Jan Fabry disease therapy nanoGLA, developed by NANBIOSIS and our partners, shows superior efficacy in preclinical trials, targeting systemic and brain symptoms. Barcelona, january 2025. An international research team led by the Institute of Materials Science of Barcelona (ICMAB-CSIC) and CIBER-BBN,[...] 26 Dec NANBIOSIS Unit 9 advances glioblastoma treatment with tailored copper nanoparticles, reducing tumor invasiveness and opening new therapeutic pathways. Zaragoza, December 2024. Our Unit 9, specialized in nanoparticle synthesis, has achieved a breakthrough in the fight against glioblastoma, one of t[...] 29 Jan Fabry disease therapy nanoGLA, developed by NANBIOSIS and our partners, shows superior efficacy in preclinical trials, targeting systemic and brain symptoms. Barcelona, january 2025. An international research team led by the Institute of Materials Science of Barcelona (ICMAB-CSIC) and CIBER-BBN,[...] 26 Dec NANBIOSIS Unit 9 advances glioblastoma treatment with tailored copper nanoparticles, reducing tumor invasiveness and opening new therapeutic pathways. Zaragoza, December 2024. Our Unit 9, specialized in nanoparticle synthesis, has achieved a breakthrough in the fight against glioblastoma, one of t[...]Welcome to Nanbiosis
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Ipsa dicta hic cupiditate dolor, aspernatur, blanditiis aperiam omnis corporis voluptatibus aut nihil a quis. Accusamus, numquam, accusantium ipsum itaque quidem expedita. Lorem ipsum dolor sit amet, consectetur adipisicing elit.Welcome to Nanbiosis - Infrastructure on Production and characterization of Nanomaterials, Biomaterials and systems in Biomedicine
Latest From the Blog
A Breakthrough Therapy for Fabry Disease: nanoGLA Demonstrates Promising Results
Innovative Copper-Based Nanoparticles Open New Frontiers in Glioblastoma Treatment
A Breakthrough Therapy for Fabry Disease: nanoGLA Demonstrates Promising Results
Innovative Copper-Based Nanoparticles Open New Frontiers in Glioblastoma Treatment
A Breakthrough Therapy for Fabry Disease: nanoGLA Demonstrates Promising Results
Innovative Copper-Based Nanoparticles Open New Frontiers in Glioblastoma Treatment
Units of Nanbiosis
About Nanbiosis
Responsive Design
It has never been easier to setup your website. With intuitive page builder and clear instructions, your site will be live in no time.
HiDPi Ready
With retina images, Shard looks crisp and sharp across the whole specter of devices. Simply Gorgeous!
Drag’n’drop builder
Shard is written with best code practices to date. This makes it preform well on all modern browsers and devices of all sizes
